Health
-
PublishedNovember 16, 2021
Pfizer asks U.S. regulators to approve promising anti-COVID-19 pill
It is one of a handful of pills that have recently been shown to significantly cut hospitalizations and deaths among people infected with COVID-19.
-
PublishedNovember 14, 2021
New record set Sunday for COVID hospitalizations in Maine
The state's 249 hospitalizations surpass the previous high of 248 set Friday. The number of patients in critical care has also increased.
-
PublishedNovember 10, 2021
Maine’s COVID-19 infections keep climbing as virus spreads among the unvaccinated
Two hospitals serving parts of the state with lower vaccination rates have seen the number of patients with the virus spike to the highest levels since the pandemic began.
-
PublishedNovember 9, 2021
Pfizer asks FDA to approve COVID-19 booster shots for all adults
Older Americans and other groups particularly vulnerable to the virus have had access to a third dose of the Pfizer and BioNTech vaccine since September.
-
PublishedNovember 5, 2021
Pfizer says COVID-19 pill cut hospitalizations, death by 89% in high-risk people
Competitor Merck’s pill is already under review at the Food and Drug Administration after showing strong initial results.
-
PublishedNovember 4, 2021
U.K. authorizes Merck’s antiviral pill, first shown to treat COVID-19
The drug, molnupiravir, was licensed for adults 18 and older who have tested positive for COVID-19 and have at least one risk factor for developing severe disease.
-
PublishedOctober 31, 2021
FDA delays decision on Moderna coronavirus vaccine for adolescents to evaluate myocarditis risk
Moderna said in a news release that the FDA indicated it will take until at least January to complete the review of its application for use in 12- to 17-year- olds.
-
PublishedOctober 29, 2021
FDA clears the way for Pfizer COVID-19 vaccinations for children ages 5-11
On Tuesday, advisers to the Centers for Disease Control and Prevention will make more detailed recommendations on which youngsters should get vaccinated, with a final decision by the agency’s director expected shortly afterward.
-
PublishedOctober 29, 2021
U.S. intelligence agencies don’t expect to determine origins of COVID-19
A White House-ordered review does, however, say that analysts do not believe the virus was developed as a bioweapon and that most agencies conclude it was not genetically engineered.
-
PublishedOctober 28, 2021
Vaccine reluctance in Eastern Europe leads to painful COVID-19 cost
Russia on Thursday recorded its largest daily toll since the pandemic began and the Kremlin ordered people not to go to work until Nov. 7.
- ← Previous Page
- 1
- …
- 36
- 37
- 38
- 39
- 40
- …
- 134
- Next Page →